Hyphens Pharma International Limited (SGX:1J5)
Singapore · Delayed Price · Currency is SGD 0.3250
+0.0050 (1.56%)
At close: Jun 10, 2026
SGXC:1J5 Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 102 | 103 | 88 | 88 | 103 | 93 | |
Market Cap Growth | 15.79% | 17.54% | -0.10% | -14.81% | 11.67% | -2.12% |
Enterprise Value | 87 | 99 | 81 | 61 | 82 | 66 |
Last Close Price | 0.33 | 0.32 | 0.26 | 0.25 | 0.25 | 0.22 |
PE Ratio | 17.74 | 17.71 | 8.64 | 10.29 | 9.11 | 13.53 |
Forward PE | 8.25 | 8.77 | 7.75 | 8.88 | 9.49 | 12.88 |
PS Ratio | 0.57 | 0.58 | 0.45 | 0.52 | 0.64 | 0.74 |
PB Ratio | 1.40 | 1.43 | 1.18 | 1.34 | 1.47 | 1.69 |
P/TBV Ratio | 2.21 | 2.25 | 1.90 | 2.24 | 2.07 | 2.54 |
P/FCF Ratio | 5.66 | 5.75 | - | 16.50 | 6.34 | 17.36 |
P/OCF Ratio | 5.44 | 5.52 | 1467.17 | 15.61 | 6.13 | 15.34 |
PEG Ratio | 0.84 | 0.90 | 0.45 | 88.79 | 0.53 | 1.62 |
EV/Sales Ratio | 0.49 | 0.56 | 0.42 | 0.36 | 0.50 | 0.52 |
EV/EBITDA Ratio | 5.91 | 7.33 | 5.48 | 4.83 | 5.08 | 7.24 |
EV/EBIT Ratio | 7.31 | 8.30 | 6.11 | 5.54 | 5.65 | 8.45 |
EV/FCF Ratio | 4.84 | 5.50 | - | 11.43 | 5.00 | 12.34 |
Debt / Equity Ratio | 0.13 | 0.13 | 0.19 | 0.10 | 0.08 | 0.15 |
Debt / EBITDA Ratio | 0.64 | 0.64 | 0.86 | 0.49 | 0.33 | 0.82 |
Debt / FCF Ratio | 0.52 | 0.52 | - | 1.28 | 0.35 | 1.53 |
Net Debt / Equity Ratio | -0.24 | -0.24 | -0.12 | -0.25 | -0.44 | -0.21 |
Net Debt / EBITDA Ratio | -1.29 | -1.29 | -0.63 | -1.31 | -1.92 | -1.24 |
Net Debt / FCF Ratio | -0.97 | -0.97 | 8.29 | -3.10 | -1.89 | -2.12 |
Asset Turnover | 1.37 | 1.37 | 1.52 | 1.45 | 1.52 | 1.39 |
Inventory Turnover | 3.42 | 3.42 | 4.24 | 4.68 | 4.30 | 3.72 |
Quick Ratio | 1.30 | 1.30 | 1.18 | 1.30 | 1.67 | 1.12 |
Current Ratio | 2.03 | 2.03 | 1.84 | 1.87 | 2.24 | 1.74 |
Return on Equity (ROE) | 8.32% | 8.32% | 15.47% | 12.61% | 18.25% | 13.44% |
Return on Assets (ROA) | 5.74% | 5.74% | 6.47% | 5.85% | 8.45% | 5.39% |
Return on Invested Capital (ROIC) | 16.38% | 15.02% | 19.42% | 20.15% | 27.82% | 18.98% |
Return on Capital Employed (ROCE) | 15.60% | 15.60% | 17.00% | 15.40% | 19.40% | 13.80% |
Earnings Yield | 5.73% | 5.65% | 11.58% | 9.72% | 10.97% | 7.39% |
FCF Yield | 17.65% | 17.39% | -1.28% | 6.06% | 15.78% | 5.76% |
Dividend Yield | 4.62% | 4.67% | 5.79% | 3.43% | 4.41% | 3.04% |
Payout Ratio | 79.28% | 79.28% | 26.05% | 169.97% | 18.23% | 27.21% |
Buyback Yield / Dilution | 0.03% | 0.03% | -1.74% | 0.27% | -2.66% | -0.60% |
Total Shareholder Return | 4.64% | 4.70% | 4.06% | 3.70% | 1.75% | 2.44% |